FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner

Authors

Shuting Bai, Washington University School of Medicine in St. Louis
Hideki Kitaura, Washington University School of Medicine in St. LouisFollow
Haibo Zhao, Washington University School of Medicine in St. Louis
Ju Chen, University of California - San Diego
Judith M. Muller, Universitäts-Frauenklinik und Zentrum für Klinische Forschung
Roland Schule, Universitäts-Frauenklinik und Zentrum für Klinische Forschung
Bryant Darnay, University of Texas M.D. Anderson Cancer Center
Deborah V. Novack, Washington University School of Medicine in St. Louis
Patrick Ross, Washington University School of Medicine in St. Louis
Steven L. Teitelbaum, Washington University School of Medicine in St. Louis

Journal

The Journal of Clinical Investigation

Publication Date

2005

Volume

115

Issue

10

Inclusive Pages

2742-2751

Document Type

Open Access Publication

DOI

10.1172/JCI24921

Rights and Permissions

FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner Shuting Bai, Hideki Kitaura, Haibo Zhao, Ju Chen, Judith M. Müller, Roland Schüle, Bryant Darnay, Deborah V. Novack, F. Patrick Ross, Steven L. Teitelbaum Published in Volume 115, Issue 10 J Clin Invest. 2005; 115(10):2742–2751 doi:10.1172/JCI24921

Recommended Citation

Bai, Shuting; Kitaura, Hideki; Zhao, Haibo; Chen, Ju; Muller, Judith M.; Schule, Roland; Darnay, Bryant; Novack, Deborah V.; Ross, Patrick; and Teitelbaum, Steven L., "FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner." The Journal of Clinical Investigation. 115, 10. 2742-2751. (2005).
https://digitalcommons.wustl.edu/open_access_pubs/1457